Arteriotomy Closure Devices Market Set to Reach $2.26 Billion by 2029 with 7% Yearly Growth

How Are the key drivers contributing to the expansion of the arteriotomy closure devices market?
The proliferation of cardiovascular diseases (CVDs) is expected to significantly contribute to the expansion of the arteriotomy closure devices market in the future. Cardiovascular diseases encompass a variety of disorders impacting the heart and vascular system. The consistent rise in CVDs can be attributed to the upswing in risk factors such as poor dietary practices, lack of physical exercise, obesity, and an ageing demographic. Arteriotomy closure devices are pivotal in cardiovascular therapies as they efficiently and securely seal punctures in the artery, minimizing complications and enhancing recuperation post-procedures like catheterizations and angioplasties. As a case in point, the British Heart Foundation, a UK-based cardiovascular research charity, reported in September 2024 that approximately 7.6 million individuals, including 4 million men and 3.6 million women, in the UK are currently suffering from heart and circulatory diseases. By 2030, this figure could surge by an additional 1 million, and by 2040, totalling 2 million more than present numbers. The escalating prevalence of cardiovascular diseases (CVDs) is hence catalyzing growth in the arteriotomy closure devices market.

Get Your Arteriotomy Closure Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

What growth opportunities are expected to drive the arteriotomy closure devices market's CAGR through 2034?
The market size for arteriotomy closure devices has experienced robust growth in the past years. This trend is projected to continue, with its value expected to go from $1.61 billion in 2024 to $1.73 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%. Several factors account for this growth during the historic period, including the increased prevalence of minimally invasive surgeries, a rising tide of cardiovascular diseases, a growing use of catheterization procedures, an aging population, and the need for faster recovery times.

The market for arteriotomy closure devices is projected to witness impressive growth in the coming years, expanding to a whopping $2.26 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.0%. Numerous factors are contributing to this forecasted growth, including increasing occurrences of atherosclerosis, a rise in coronary artery diseases, a heightened emphasis on patient safety and comfort, the expansion of the healthcare infrastructure in developing countries, and an escalating demand for ambulatory surgical centers. Key trends for this period include the use of minimally invasive procedures, the adoption of bioresorbable materials, the implementation of automation in closure procedures, enhancements in procedural efficiency, and breakthroughs in closure devices for significant arterial punctures.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What are the emerging trends shaping the future of the arteriotomy closure devices market?
In the arteriotomy closure devices market, major businesses are focusing on product innovation to boost operational efficiency, enhance patient results, and cater to the growing demand for less invasive vascular access solutions. A medium-bore venous closure device is a medical instrument crafted to seal venous access spots made by medium-sized catheters or sheaths, thus enabling hemostasis and assisting in patient recuperation following interventional procedures. For instance, in June 2024, Haemonetics Corp, a healthcare company based in the United States, broadened its VASCADE range by introducing the VASCADE MVP XL medium-bore venous closure device. This specialized device for larger sheaths (10-12F, up to 15F outer diameter), used in procedures such as cryoablation, features a 58% increase in collagen and a larger collapsible disc for quick hemostasis. This addition to Haemonetics' existing lineup of small and medium bore vascular closure solutions emphasizes the company's dominance in advanced closure technologies.

Which growth-oriented segments of the arteriotomy closure devices market are leading the industry's development?
The arteriotomy closure devices market covered in this report is segmented -

1) By Product: Active Closure Devices, Passive Closure Devices
2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures
3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:
1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices
2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20712

What regions are leading the charge in the arteriotomy closure devices market?
North America was the largest region in the arteriotomy closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the arteriotomy closure devices market?
Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

What Is Covered In The Arteriotomy Closure Devices Global Market Report?

•Market Size Forecast: Examine the arteriotomy closure devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the arteriotomy closure devices market for a structured understanding.
•Key Players Overview: Analyze major players in the arteriotomy closure devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the arteriotomy closure devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the arteriotomy closure devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the arteriotomy closure devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the arteriotomy closure devices market.
•Competitive Landscape: Review strategic developments in the arteriotomy closure devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.